PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Oct-2023 Enanta Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss Advances in the Treatment Landscape for Respiratory Syncytial Virus (RSV) and its Proprietary RSV Pipeline Businesswire
13-Oct-2023 United State Medical Spa Industry Analysis from 2022 To 2032 by Service & Region | FMI Unveils the Trends MARKITWIRED
13-Oct-2023 Adrenocorticotropic Hormone (ACTH) Market to Exhibit a Striking Growth of USD 2.20 Billion By 2029 The Wire Times
13-Oct-2023 Cystic Fibrosis Transmembrane conductance Regulator (CFTR) Market to Garner USD 42.23 Billion By 2030 The Wire Times
13-Oct-2023 Denys-Drash Syndrome Market to Obtain Overwhelming Growth of USD 459.98 Million By 2029 The Wire Times
13-Oct-2023 Inhalation and Nasal Spray Generic Drugs Industry’s Spectacular Rise to a US$49.01 Billion Valuation by 2033 | FMI Analysis MARKITWIRED
13-Oct-2023 Pupillometer Industry Heading Towards a US$809.56 Million Valuation by 2033 with a Steady 7.7% CAGR | FMI Insights MARKITWIRED
13-Oct-2023 PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million PAION AG
13-Oct-2023 PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million PAION AG
13-Oct-2023 AT-Home Testing Market Sets New Record, Projected at USD 45.58 billion by 2031 at 10.5% CAGR The Wire Times
13-Oct-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
13-Oct-2023 Health and Wellness Market Sets New Record, Projected at USD 12.9 Trillion, Globally, by 2031 at 10.9% CAGR The Wire Times
13-Oct-2023 Almirall's lebrikizumab improves signs and symptoms of moderate-to-severe atopic dermatitis (AD) in patients inadequately controlled with or ineligible for cyclosporine1 Almirall S.A.
13-Oct-2023 Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa UCB
13-Oct-2023 AbbVie Announces Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo as Program Advances to Phase 3 AbbVie
13-Oct-2023 ABB and ODS partnership to enable precise and reliable custody transfer ABB
13-Oct-2023 Disposable Bronchoscopes Market Valued at US$ 2.9 Billion by 2032 | Future Market Insights,Inc. MARKITWIRED
13-Oct-2023 RTW Biotech Opportunities Ltd Monthly Valuation Update, September Factsheet & Third Quarter Letter RTW Biotech Opportunities Ltd
13-Oct-2023 Orthopedic Implants Market would rise to USD 74,833.27 million by 2030 The Wire Times
13-Oct-2023 Europe Medical cannabis Market is expected to grow at a CAGR of 22.5% by 2030 The Wire Times